MAP Pharmaceuticals Inc. (MAPP)
NASDAQ: Health Care
$12.15
0.76 | 6.67%
0.76 | 6.67%
Today's Range:
11.36 -
12.21
MAPP Avg. Daily Volume:
644,100
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 12.15 |
| 52 Week High | 17.92 |
| 52 Week Low | 10.54 |
| Avg. Daily Vol. (Mil) | 0.64 |
| Beta (3 year) | 2.82 |
| Share Related Items | |
| Mkt Cap (Mil) | 372.52 |
| Shares Out (Mil) | 30.66 |
| Float (Mil) | 22.78 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 7.20 |
| Current Ratio | 7.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | -37.01 |
| Price/Book | 15.40 |
| Price/Cash Flow | -5.60 |
| Per Share Data | |
| Earnings | -2.23 |
| Sales | -0.33 |
| Book Value | 0.79 |
| Cash Flow | -2.18 |
| Business Summary | |
|---|---|
| MAP Pharmaceuticals, Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. | |
| General Information | |
| 2400 Bayshore Parkway
Suite 200 Mountain View, CA 94043 |
|
| www.mappharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 122 | |
| CEO: Timothy S. Nelson | |
| Short Interest | |
| Current Month (Mil) | 4.87 |
| Previous Month (Mil) | 4.59 |
| Short Interest Ratio (Days) | 17.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -78.00 |
| Return on Investments | -282.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet